GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » LT-Debt-to-Total-Asset

Bangkok Lab and Cosmetic PCL (BKK:BLC) LT-Debt-to-Total-Asset : 0.03 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bangkok Lab and Cosmetic PCL LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bangkok Lab and Cosmetic PCL's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.03.

Bangkok Lab and Cosmetic PCL's long-term debt to total assets ratio declined from Mar. 2023 (0.08) to Mar. 2024 (0.03). It may suggest that Bangkok Lab and Cosmetic PCL is progressively becoming less dependent on debt to grow their business.


Bangkok Lab and Cosmetic PCL LT-Debt-to-Total-Asset Historical Data

The historical data trend for Bangkok Lab and Cosmetic PCL's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Lab and Cosmetic PCL LT-Debt-to-Total-Asset Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
0.10 0.09 0.03

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.04 0.04 0.03 0.03

Bangkok Lab and Cosmetic PCL LT-Debt-to-Total-Asset Calculation

Bangkok Lab and Cosmetic PCL's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=75.949/2240.253
=0.03

Bangkok Lab and Cosmetic PCL's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=69.912/2212.335
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Lab and Cosmetic PCL  (BKK:BLC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Bangkok Lab and Cosmetic PCL LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Bangkok Lab and Cosmetic PCL's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Lab and Cosmetic PCL (BKK:BLC) Business Description

Traded in Other Exchanges
N/A
Address
Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. Its operation covers the complete value chain of the healthcare business. Its product portfolio comprises generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. Its operation ranges from research and development, manufacturing with international standards, sales, and marketing, to distribution to partnering businesses and customers.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Headlines

No Headlines